Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 30.91M | $686.0M | 18.66% | +126.5K | 2026-06-30 |
| BlackRock, Inc. | 12.40M | $275.0M | 7.49% | +704.5K | 2026-06-30 |
| Jupiter Topco LLC | 12.00M | $266.0M | 7.24% | -- | 2026-06-30 |
| FMR LLC | 11.21M | $248.0M | 6.76% | +2.30M | 2026-06-30 |
| STATE STREET CORP | 7.46M | $165.0M | 4.50% | +804.5K | 2026-06-30 |
| Orbis Allan Gray Ltd | 7.01M | $155.0M | 4.23% | +244.3K | 2026-06-30 |
| Atlas Venture Life Science Advisors, LLC | 6.80M | $151.0M | 4.10% | -2.33M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.31M | $140.0M | 3.81% | -94.1K | 2026-06-30 |
| TCG Crossover Management, LLC | 4.62M | $102.0M | 2.79% | -- | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.05M | $89.0M | 2.44% | -113.6K | 2026-06-30 |
